Potassium Competitive Acid Blocker (PCAB) Test-Guided vs Physiologic Test-Guided Treatment in Patients With Typical Reflux Symptoms | MicrobiomeTrials← Back to trialsNCT07707011
Potassium Competitive Acid Blocker (PCAB) Test-Guided vs Physiologic Test-Guided Treatment in Patients With Typical Reflux Symptoms
ENROLLING_BY_INVITATIONNAINTERVENTIONAL
Trial Details
Start: 2026-03-18Est. Completion: 2027-03
Enrollment target: 120 participants Locations- Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok Noi, Bangkok, Thailand
Other microbiome trials you might be interested in
Gastroesophageal Reflux
This study will be conducted as a multi-center, randomized, double-blind, placebo-controlled trial to evaluate the effec…
Phoenix, United StatesCompleted May 27, 2026
Gastro Esophageal Reflux Disorder
A randomized, open-label, multiple-dose, crossover phase 1 clinical trial to compare and evaluate the safety, pharmacoki…
Cheongju-si, South KoreaEst. completion Aug 2026
Completed
Mitral Valve Regurgitation
The purpose of this study is to evaluate the safety and initial performance of the Neovasc Tiara Mitral Transcatheter He…
Los Angeles, United StatesCompleted Jan 6, 2020